The cyclin-dependent kinases (Cdks) regulate many cellular processes, including the cell cycle, neuronal development, transcription, and posttranscriptional processing. To perform their functions, Cdks bind to specific cyclin subunits to form a functional and active cyclin/Cdk complex. This review is focused on Cyclin K, which was originally considered an alternative subunit of Cdk9, and on its newly identified partners, Cdk12 and Cdk13. We briefly summarize research devoted to each of these proteins. We also discuss the proteins' functions in the regulation of gene expression via the phosphorylation of serine 2 in the C-terminal domain of RNA polymerase II, contributions to the maintenance of genome stability, and roles in the onset of human disease and embryo development.

Central European Institute of Technology Masaryk University 62500 Brno Czech Republic

Zobrazit více v PubMed

Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, Morgan DO, Tsai LH, Wolgemuth DJ. Cyclin-dependent kinases: a family portrait. Nat Cell Biol. 2009;11(11):1275–1276. doi: 10.1038/ncb1109-1275. PubMed DOI PMC

Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene. 2009;28(33):2925–2939. doi: 10.1038/onc.2009.170. PubMed DOI

Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153–166. doi: 10.1038/nrc2602. PubMed DOI

Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol Cell. 2009;36(4):541–546. doi: 10.1016/j.molcel.2009.10.019. PubMed DOI PMC

Blazek D, Kohoutek J, Bartholomeeusen K, Johansen E, Hulinkova P, Luo Z, Cimermancic P, Ule J, Peterlin BM. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 2011;25(20):2158–2172. doi: 10.1101/gad.16962311. PubMed DOI PMC

Bartkowiak B, Liu P, Phatnani HP, Fuda NJ, Cooper JJ, Price DH, Adelman K, Lis JT, Greenleaf AL. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 2010;24(20):2303–2316. doi: 10.1101/gad.1968210. PubMed DOI PMC

Blazek D. The cyclin K/Cdk12 complex: An emerging new player in the maintenance of genome stability. Cell Cycle. 2012;11:(6):1049–1050. PubMed PMC

Buratowski S. The CTD code. Nat Struct Biol. 2003;10(9):679–680. doi: 10.1038/nsb0903-679. PubMed DOI

Zeitlinger J, Stark A, Kellis M, Hong JW, Nechaev S, Adelman K, Levine M, Young RA. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat Genet. 2007;39(12):1512–1516. doi: 10.1038/ng.2007.26. PubMed DOI PMC

Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, Zeitlinger J, Adelman K. RNA polymerase is poised for activation across the genome. Nat Genet. 2007;39(12):1507–1511. doi: 10.1038/ng.2007.21. PubMed DOI PMC

Pandit S, Wang D, Fu XD. Functional integration of transcriptional and RNA processing machineries. Curr Opin Cell Biol. 2008;20(3):260–265. doi: 10.1016/j.ceb.2008.03.001. PubMed DOI PMC

Perales R, Bentley D. "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol Cell. 2009;36(2):178–191. doi: 10.1016/j.molcel.2009.09.018. PubMed DOI PMC

Moore MJ, Proudfoot NJ. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell. 2009;136(4):688–700. doi: 10.1016/j.cell.2009.02.001. PubMed DOI

Wood A, Shilatifard A. Bur1/Bur2 and the Ctk complex in yeast: the split personality of mammalian P-TEFb. Cell Cycle. 2006;5(10):1066–1068. doi: 10.4161/cc.5.10.2769. PubMed DOI

Edwards MC, Wong C, Elledge SJ. Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Mol Cell Biol. 1998;18(7):4291–4300. PubMed PMC

Fu TJ, Peng J, Lee G, Price DH, Flores O. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J Biol Chem. 1999;274(49):34527–34530. doi: 10.1074/jbc.274.49.34527. PubMed DOI

Peng J, Zhu Y, Milton JT, Price DH. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 1998;12(5):755–762. doi: 10.1101/gad.12.5.755. PubMed DOI PMC

Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998;92(4):451–462. doi: 10.1016/S0092-8674(00)80939-3. PubMed DOI

Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol. 2000;20(8):2629–2634. doi: 10.1128/MCB.20.8.2629-2634.2000. PubMed DOI PMC

Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol Cell. 2006;23(3):297–305. doi: 10.1016/j.molcel.2006.06.014. PubMed DOI

Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 1998;12(22):3512–3527. doi: 10.1101/gad.12.22.3512. PubMed DOI PMC

Lin X, Taube R, Fujinaga K, Peterlin BM. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. J Biol Chem. 2002;277(19):16873–16878. doi: 10.1074/jbc.M200117200. PubMed DOI

Barboric M, Lenasi T, Chen H, Johansen EB, Guo S, Peterlin BM. 7SK snRNP/P-TEFb couples transcription elongation with alternative splicing and is essential for vertebrate development. Proc Natl Acad Sci USA. 2009;106(19):7798–7803. doi: 10.1073/pnas.0903188106. PubMed DOI PMC

Bezstarosti K, Ghamari A, Grosveld FG, Demmers JA. Differential proteomics based on 18O labeling to determine the cyclin dependent kinase 9 interactome. J Proteome Res. 2010;9(9):4464–4475. doi: 10.1021/pr100217d. PubMed DOI

Ko TK, Kelly E, Pines J. CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. J Cell Sci. 2001;114(Pt 14):2591–2603. PubMed

Marques F, Moreau JL, Peaucellier G, Lozano JC, Schatt P, Picard A, Callebaut I, Perret E, Geneviere AM. A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. Biochem Biophys Res Commun. 2000;279(3):832–837. doi: 10.1006/bbrc.2000.4042. PubMed DOI

Even Y, Durieux S, Escande ML, Lozano JC, Peaucellier G, Weil D, Geneviere AM. CDC2L5, a Cdk-like kinase with RS domain, interacts with the ASF/SF2-associated protein p32 and affects splicing in vivo. J Cell Biochem. 2006;99(3):890–904. doi: 10.1002/jcb.20986. PubMed DOI

Chen HH, Wang YC, Fann MJ. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation. Mol Cell Biol. 2006;26(7):2736–2745. doi: 10.1128/MCB.26.7.2736-2745.2006. PubMed DOI PMC

Chen HH, Wong YH, Geneviere AM, Fann MJ. CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochem Biophys Res Commun. 2007;354(3):735–740. doi: 10.1016/j.bbrc.2007.01.049. PubMed DOI

Liu J, Kipreos ET. Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol Biol Evol. 2000;17(7):1061–1074. doi: 10.1093/oxfordjournals.molbev.a026387. PubMed DOI

Guo Z, Stiller JW. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs. BMC Genomics. 2004;5:69. doi: 10.1186/1471-2164-5-69. PubMed DOI PMC

Morgan DO, De Bondt HL. Protein kinase regulation: insights from crystal structure analysis. Curr Opin Cell Biol. 1994;6(2):239–246. doi: 10.1016/0955-0674(94)90142-2. PubMed DOI

Komarnitsky P, Cho EJ, Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 2000;14(19):2452–2460. doi: 10.1101/gad.824700. PubMed DOI PMC

Akhtar MS, Heidemann M, Tietjen JR, Zhang DW, Chapman RD, Eick D, Ansari AZ. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol Cell. 2009;34(3):387–393. doi: 10.1016/j.molcel.2009.04.016. PubMed DOI PMC

Glover-Cutter K, Larochelle S, Erickson B, Zhang C, Shokat K, Fisher RP, Bentley DL. TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol. 2009;29(20):5455–5464. doi: 10.1128/MCB.00637-09. PubMed DOI PMC

Tassan JP, Jaquenoud M, Leopold P, Schultz SJ, Nigg EA. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci USA. 1995;92(19):8871–8875. doi: 10.1073/pnas.92.19.8871. PubMed DOI PMC

Rickert P, Seghezzi W, Shanahan F, Cho H, Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene. 1996;12(12):2631–2640. PubMed

Shore SM, Byers SA, Maury W, Price DH. Identification of a novel isoform of Cdk9. Gene. 2003;307:175–182. PubMed

Loyer P, Trembley JH, Grenet JA, Busson A, Corlu A, Zhao W, Kocak M, Kidd VJ, Lahti JM. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J Biol Chem. 2008;283(12):7721–7732. doi: 10.1074/jbc.M708188200. PubMed DOI

Ji Y, Xiao F, Sun L, Qin J, Shi S, Yang J, Liu Y, Zhou D, Zhao J, Shen A. Increased expression of CDK11p58 and cyclin D3 following spinal cord injury in rats. Mol Cell Biochem. 2008;309(1-2):49–60. doi: 10.1007/s11010-007-9642-z. PubMed DOI

Dickinson LA, Edgar AJ, Ehley J, Gottesfeld JM. Cyclin L is an RS domain protein involved in pre-mRNA splicing. J Biol Chem. 2002;277(28):25465–25473. doi: 10.1074/jbc.M202266200. PubMed DOI

Baek K, Brown RS, Birrane G, Ladias JA. Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. J Mol Biol. 2007;366(2):563–573. doi: 10.1016/j.jmb.2006.11.057. PubMed DOI PMC

Sudol M, Sliwa K, Russo T. Functions of WW domains in the nucleus. FEBS Lett. 2001;490(3):190–195. doi: 10.1016/S0014-5793(01)02122-6. PubMed DOI

Fisher RP. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J Cell Sci. 2005;118(Pt 22):5171–5180. PubMed

Morgan DO. Principles of CDK regulation. Nature. 1995;374(6518):131–134. doi: 10.1038/374131a0. PubMed DOI

Hertel KJ, Graveley BR. RS domains contact the pre-mRNA throughout spliceosome assembly. Trends Biochem Sci. 2005;30(3):115–118. doi: 10.1016/j.tibs.2005.01.002. PubMed DOI

Long JC, Caceres JF. The SR protein family of splicing factors: master regulators of gene expression. Biochem J. 2009;417(1):15–27. doi: 10.1042/BJ20081501. PubMed DOI

Mortillaro MJ, Blencowe BJ, Wei X, Nakayasu H, Du L, Warren SL, Sharp PA, Berezney R. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci USA. 1996;93(16):8253–8257. doi: 10.1073/pnas.93.16.8253. PubMed DOI PMC

de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein M, Pelisch F, Cramer P, Bentley D, Kornblihtt AR. A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell. 2003;12(2):525–532. doi: 10.1016/j.molcel.2003.08.001. PubMed DOI

de la Mata M, Kornblihtt AR. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat Struct Mol Biol. 2006;13(11):973–980. doi: 10.1038/nsmb1155. PubMed DOI

Berro R, Pedati C, Kehn-Hall K, Wu W, Klase Z, Even Y, Geneviere AM, Ammosova T, Nekhai S, Kashanchi F. CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing. J Virol. 2008;82(14):7155–7166. doi: 10.1128/JVI.02543-07. PubMed DOI PMC

Ball LJ, Kuhne R, Schneider-Mergener J, Oschkinat H. Recognition of proline-rich motifs by protein-protein-interaction domains. Angew Chem Int Ed Engl. 2005;44(19):2852–2869. doi: 10.1002/anie.200400618. PubMed DOI

Sims RJ III, Belotserkovskaya R, Reinberg D. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 2004;18(20):2437–2468. doi: 10.1101/gad.1235904. PubMed DOI

Fuda NJ, Ardehali MB, Lis JT. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature. 2009;461(7261):186–192. doi: 10.1038/nature08449. PubMed DOI PMC

Lenasi T, Barboric M. P-TEFb stimulates transcription elongation and pre-mRNA splicing through multilateral mechanisms. RNA Biol. 2010;7(2):145–150. doi: 10.4161/rna.7.2.11057. PubMed DOI

Egloff S, Murphy S. Cracking the RNA polymerase II CTD code. Trends Genet. 2008;24(6):280–288. doi: 10.1016/j.tig.2008.03.008. PubMed DOI

Phatnani HP, Greenleaf AL. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006;20(21):2922–2936. doi: 10.1101/gad.1477006. PubMed DOI

Hsin JP, Sheth A, Manley JL. RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3' end processing. Science. 2011;334(6056):683–686. doi: 10.1126/science.1206034. PubMed DOI PMC

Palancade B, Bensaude O. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur J Biochem. 2003;270(19):3859–3870. doi: 10.1046/j.1432-1033.2003.03794.x. PubMed DOI

Chapman RD, Heidemann M, Albert TK, Mailhammer R, Flatley A, Meisterernst M, Kremmer E, Eick D. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science. 2007;318(5857):1780–1782. doi: 10.1126/science.1145977. PubMed DOI

Jones JC, Phatnani HP, Haystead TA, MacDonald JA, Alam SM, Greenleaf AL. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem. 2004;279(24):24957–24964. doi: 10.1074/jbc.M402218200. PubMed DOI PMC

Allison LA, Wong JK, Fitzpatrick VD, Moyle M, Ingles CJ. The C-terminal domain of the largest subunit of RNA polymerase II of Saccharomyces cerevisiae, Drosophila melanogaster, and mammals: a conserved structure with an essential function. Mol Cell Biol. 1988;8(1):321–329. PubMed PMC

Bartkowiak B, Greenleaf AL. Phosphorylation of RNAPII: To P-TEFb or not to P-TEFb? Transcription. 2011;2(3):115–119. doi: 10.4161/trns.2.3.15004. PubMed DOI PMC

Chao SH, Price DH. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem. 2001;276(34):31793–31799. doi: 10.1074/jbc.M102306200. PubMed DOI

Nechaev S, Adelman K. Promoter-proximal Pol II: when stalling speeds things up. Cell Cycle. 2008;7(11):1539–1544. doi: 10.4161/cc.7.11.6006. PubMed DOI

Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. c-Myc regulates transcriptional pause release. Cell. 2010;141(3):432–445. doi: 10.1016/j.cell.2010.03.030. PubMed DOI PMC

Cho EJ, Kobor MS, Kim M, Greenblatt J, Buratowski S. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev. 2001;15(24):3319–3329. doi: 10.1101/gad.935901. PubMed DOI PMC

Liu Y, Warfield L, Zhang C, Luo J, Allen J, Lang WH, Ranish J, Shokat KM, Hahn S. Phosphorylation of the transcription elongation factor Spt5 by yeast Bur1 kinase stimulates recruitment of the PAF complex. Mol Cell Biol. 2009;29(17):4852–4863. doi: 10.1128/MCB.00609-09. PubMed DOI PMC

Qiu H, Hu C, Hinnebusch AG. Phosphorylation of the Pol II CTD by KIN28 enhances BUR1/BUR2 recruitment and Ser2 CTD phosphorylation near promoters. Mol Cell. 2009;33(6):752–762. doi: 10.1016/j.molcel.2009.02.018. PubMed DOI PMC

Ahn SH, Kim M, Buratowski S. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. Mol Cell. 2004;13(1):67–76. doi: 10.1016/S1097-2765(03)00492-1. PubMed DOI

Kim H, Erickson B, Luo W, Seward D, Graber JH, Pollock DD, Megee PC, Bentley DL. Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat Struct Mol Biol. 2010;17(10):1279–1286. doi: 10.1038/nsmb.1913. PubMed DOI PMC

Bataille AR, Jeronimo C, Jacques PE, Laramee L, Fortin ME, Forest A, Bergeron M, Hanes SD, Robert F. A Universal RNA Polymerase II CTD Cycle Is Orchestrated by Complex Interplays between Kinase, Phosphatase, and Isomerase Enzymes along Genes. Mol Cell. 2012;45(2):158–170. doi: 10.1016/j.molcel.2011.11.024. PubMed DOI

Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071–1078. doi: 10.1038/nature08467. PubMed DOI PMC

Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179–204. doi: 10.1016/j.molcel.2010.09.019. PubMed DOI PMC

Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y. et al.ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316(5828):1160–1166. doi: 10.1126/science.1140321. PubMed DOI

Paulsen RD, Soni DV, Wollman R, Hahn AT, Yee MC, Guan A, Hesley JA, Miller SC, Cromwell EF, Solow-Cordero DE. et al.A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol Cell. 2009;35(2):228–239. doi: 10.1016/j.molcel.2009.06.021. PubMed DOI PMC

Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9(8):616–627. doi: 10.1038/nrm2450. PubMed DOI PMC

Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER III, Hurov KE, Luo J, Ballif BA, Gygi SP, Hofmann K, D'Andrea AD. et al.Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129(2):289–301. doi: 10.1016/j.cell.2007.03.009. PubMed DOI PMC

Moldovan GL, D'Andrea AD. How the fanconi anemia pathway guards the genome. Annu Rev Genet. 2009;43:223–249. doi: 10.1146/annurev-genet-102108-134222. PubMed DOI PMC

Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007;28(5):739–745. doi: 10.1016/j.molcel.2007.11.015. PubMed DOI

O'Connell BC, Adamson B, Lydeard JR, Sowa ME, Ciccia A, Bredemeyer AL, Schlabach M, Gygi SP, Elledge SJ, Harper JW. A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic Stability. Mol Cell. 2010;40(4):645–657. doi: 10.1016/j.molcel.2010.10.022. PubMed DOI PMC

Munoz MJ, de la Mata M, Kornblihtt AR. The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem Sci. 2010;35(9):497–504. doi: 10.1016/j.tibs.2010.03.010. PubMed DOI

Ostapenko D, Solomon MJ. Budding yeast CTDK-I is required for DNA damage-induced transcription. Eukaryot Cell. 2003;2(2):274–283. doi: 10.1128/EC.2.2.274-283.2003. PubMed DOI PMC

Yu DS, Zhao R, Hsu EL, Cayer J, Ye F, Guo Y, Shyr Y, Cortez D. Cyclin-dependent kinase 9-cyclin K functions in the replication stress response. EMBO Rep. 2010;11(11):876–882. doi: 10.1038/embor.2010.153. PubMed DOI PMC

Mori T, Anazawa Y, Matsui K, Fukuda S, Nakamura Y, Arakawa H. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia. 2002;4(3):268–274. doi: 10.1038/sj.neo.7900235. PubMed DOI PMC

Clausing E, Mayer A, Chanarat S, Muller B, Germann SM, Cramer P, Lisby M, Strasser K. The transcription elongation factor Bur1-Bur2 interacts with replication protein A and maintains genome stability during replication stress. J Biol Chem. 2010;285(53):41665–41674. doi: 10.1074/jbc.M110.193292. PubMed DOI PMC

Liu H, Herrmann CH, Chiang K, Sung TL, Moon SH, Donehower LA, Rice AP. 55K isoform of CDK9 associates with Ku70 and is involved in DNA repair. Biochem Biophys Res Commun. 2010;397(2):245–250. doi: 10.1016/j.bbrc.2010.05.092. PubMed DOI PMC

The Cancer Research Atlas Genome Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:(7353):609–615. PubMed PMC

Kauraniemi P, Barlund M, Monni O, Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res. 2001;61(22):8235–8240. PubMed

Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am J Pathol. 2003;163(5):1979–1984. doi: 10.1016/S0002-9440(10)63556-0. PubMed DOI PMC

Benusiglio PR, Pharoah PD, Smith PL, Lesueur F, Conroy D, Luben RN, Dew G, Jordan C, Dunning A, Easton DF. et al.HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. Br J Cancer. 2006;95(12):1689–1695. doi: 10.1038/sj.bjc.6603473. PubMed DOI PMC

Sircoulomb F, Bekhouche I, Finetti P, Adelaide J, Ben Hamida A, Bonansea J, Raynaud S, Innocenti C, Charafe-Jauffret E, Tarpin C. et al.Genome profiling of ERBB2-amplified breast cancers. BMC Cancer. 2010;10:539. doi: 10.1186/1471-2407-10-539. PubMed DOI PMC

Zang ZJ, Ong CK, Cutcutache I, Yu W, Zhang SL, Huang D, Ler LD, Dykema K, Gan A, Tao J. et al.Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Cancer Res. 2011;71(1):29–39. doi: 10.1158/0008-5472.CAN-10-1749. PubMed DOI PMC

Iorns E, Martens-de Kemp SR, Lord CJ, Ashworth A. CRK7 modifies the MAPK pathway and influences the response to endocrine therapy. Carcinogenesis. 2009;30(10):1696–1701. doi: 10.1093/carcin/bgp187. PubMed DOI

Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D. et al.Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet. 1999;21(2):236–240. doi: 10.1038/6029. PubMed DOI

Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 1995;9(4):444–450. doi: 10.1038/ng0495-444. PubMed DOI

Malcovati L, Della Porta MG, Pietra D, Boveri E, Pellagatti A, Galli A, Travaglino E, Brisci A, Rumi E, Passamonti F. et al.Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood. 2009;114(17):3538–3545. doi: 10.1182/blood-2009-05-222331. PubMed DOI

Lapidot-Lifson Y, Patinkin D, Prody CA, Ehrlich G, Seidman S, Ben-Aziz R, Benseler F, Eckstein F, Zakut H, Soreq H. Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis. Proc Natl Acad Sci USA. 1992;89(2):579–583. doi: 10.1073/pnas.89.2.579. PubMed DOI PMC

Khan SZ, Mitra D. Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner. J Biol Chem. 2011;286(26):22943–22954. doi: 10.1074/jbc.M110.201194. PubMed DOI PMC

Kulkarni PA, Sano M, Schneider MD. Phosphorylation of RNA polymerase II in cardiac hypertrophy: cell enlargement signals converge on cyclin T/Cdk9. Recent Prog Horm Res. 2004;59:125–139. doi: 10.1210/rp.59.1.125. PubMed DOI

Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, Florens L, Washburn MP, Conaway JW, Conaway RC, Shilatifard A. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell. 2010;37(3):429–437. doi: 10.1016/j.molcel.2010.01.026. PubMed DOI PMC

Mueller D, Bach C, Zeisig D, Garcia-Cuellar MP, Monroe S, Sreekumar A, Zhou R, Nesvizhskii A, Chinnaiyan A, Hess JL. et al.A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood. 2007;110(13):4445–4454. doi: 10.1182/blood-2007-05-090514. PubMed DOI PMC

Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet. 2007;16(1):92–106. PubMed

He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A, Krogan NJ, Alber T, Zhou Q. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol Cell. 2010;38(3):428–438. doi: 10.1016/j.molcel.2010.04.013. PubMed DOI PMC

Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell. 2010;38(3):439–451. doi: 10.1016/j.molcel.2010.04.012. PubMed DOI PMC

Krystof V, Chamrad I, Jorda R, Kohoutek J. Pharmacological targeting of CDK9 in cardiac hypertrophy. Med Res Rev. 2010;30(4):646–666. PubMed

Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM, Price DH. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem. 2000;275(37):28345–28348. PubMed

Kohoutek J, Li Q, Blazek D, Luo Z, Jiang H, Peterlin BM. Cyclin T2 is essential for mouse embryogenesis. Mol Cell Biol. 2009;29(12):3280–3285. doi: 10.1128/MCB.00172-09. PubMed DOI PMC

Westerling T, Kuuluvainen E, Makela TP. Cdk8 is essential for preimplantation mouse development. Mol Cell Biol. 2007;27(17):6177–6182. doi: 10.1128/MCB.01302-06. PubMed DOI PMC

Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 2000;14(4):397–402. PubMed PMC

de Klein A, Muijtjens M, van Os R, Verhoeven Y, Smit B, Carr AM, Lehmann AR, Hoeijmakers JH. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr Biol. 2000;10(8):479–482. doi: 10.1016/S0960-9822(00)00447-4. PubMed DOI

Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F. et al.The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 1996;85(7):1009–1023. doi: 10.1016/S0092-8674(00)81302-1. PubMed DOI

Neumuller RA, Richter C, Fischer A, Novatchkova M, Neumuller KG, Knoblich JA. Genome-wide analysis of self-renewal in Drosophila neural stem cells by transgenic RNAi. Cell Stem Cell. 2011;8(5):580–593. doi: 10.1016/j.stem.2011.02.022. PubMed DOI PMC

Zhu H, Doherty JR, Kuliyev E, Mead PE. CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer. Dev Dyn. 2009;238(6):1346–1357. doi: 10.1002/dvdy.21920. PubMed DOI PMC

CDK11 is required for transcription of replication-dependent histone genes

CDK12: cellular functions and therapeutic potential of versatile player in cancer

CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes

Mouse Model of Congenital Heart Defects, Dysmorphic Facial Features and Intellectual Developmental Disorders as a Result of Non-functional CDK13

Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex